Identification and Characterization of Synaptic Vesicle Membrane Protein VAT-1 Homolog as a New Catechin-Binding Protein.

(−)-epigallocatechin-3-gallate (EGCg) binding protein neprilysin pull-down assay surface plasmon resonance synaptic vesicle membrane protein VAT-1 homolog (VAT1)

Journal

Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984

Informations de publication

Date de publication:
2024
Historique:
medline: 26 2 2024
pubmed: 26 2 2024
entrez: 25 2 2024
Statut: ppublish

Résumé

(-)-Epigallocatechin-3-gallate (EGCg), a major constituent of green tea extract, is well-known to exhibit many beneficial actions for human health by interacting with numerous proteins. In this study we identified synaptic vesicle membrane protein VAT-1 homolog (VAT1) as a novel EGCg-binding protein in human neuroglioma cell extracts using a magnetic pull-down assay and LC-tandem mass spectrometry. We prepared recombinant human VAT1 and analyzed its direct binding to EGCg and its alkylated derivatives using surface plasmon resonance. For EGCg and the derivative NUP-15, we measured an association constant of 0.02-0.85 ×10

Identifiants

pubmed: 38403661
doi: 10.1248/bpb.b23-00830
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

509-517

Auteurs

Ayaka Ikemizu (A)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.

Daisuke Hatta (D)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.

Kohei Fujimoto (K)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.

Mikako Honda (M)

Faculty of Pharmaceutical Sciences, Nagasaki University.

Kaori Watanabe (K)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.

Kaname Ohyama (K)

Department of Hospital Pharmacy, Nagasaki University Hospital.

Naotaka Kuroda (N)

Department of Analytical Chemistry for Pharmaceuticals, Graduate School of Biomedical Sciences, Nagasaki University.

Takashi Tanaka (T)

Department of Natural Product Chemistry, Graduate School of Biomedical Sciences, Nagasaki University.

Keiro Shirotani (K)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
Faculty of Pharmaceutical Sciences, Nagasaki University.
Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University.

Nobuhisa Iwata (N)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
Faculty of Pharmaceutical Sciences, Nagasaki University.
Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University.

Classifications MeSH